These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 18655041

  • 1. Optimization and validation of a reporter gene assay for screening of phosphodiesterase inhibitors in a high throughput system.
    Nanda K, Chatterjee M, Arya R, Mukherjee S, Saini KS, Dastidar S, Ray A.
    Biotechnol J; 2008 Oct; 3(9-10):1276-9. PubMed ID: 18655041
    [Abstract] [Full Text] [Related]

  • 2. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):110-7. PubMed ID: 16458289
    [Abstract] [Full Text] [Related]

  • 3. A reporter gene assay for screening of PDE4 subtype selective inhibitors.
    Bora RS, Malik R, Arya R, Gupta D, Singh V, Aggarwal N, Dastidar S, Ray A, Saini KS.
    Biochem Biophys Res Commun; 2007 Apr 27; 356(1):153-8. PubMed ID: 17336928
    [Abstract] [Full Text] [Related]

  • 4. Real-time monitoring of phosphodiesterase inhibition in intact cells.
    Herget S, Lohse MJ, Nikolaev VO.
    Cell Signal; 2008 Aug 27; 20(8):1423-31. PubMed ID: 18467075
    [Abstract] [Full Text] [Related]

  • 5. Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors.
    Castro A, Jerez MJ, Gil C, Martinez A.
    Med Res Rev; 2005 Mar 27; 25(2):229-44. PubMed ID: 15514991
    [Abstract] [Full Text] [Related]

  • 6. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
    Santos-Silva AJ, Cairrão E, Morgado M, Alvarez E, Verde I.
    Eur J Pharmacol; 2008 Mar 17; 582(1-3):102-9. PubMed ID: 18234184
    [Abstract] [Full Text] [Related]

  • 7. Implications of PDE4 structure on inhibitor selectivity across PDE families.
    Ke H.
    Int J Impot Res; 2004 Jun 17; 16 Suppl 1():S24-7. PubMed ID: 15224132
    [Abstract] [Full Text] [Related]

  • 8. Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue.
    Uckert S, Sormes M, Kedia G, Scheller F, Knapp WH, Jonas U, Stief CG.
    Urology; 2008 Mar 17; 71(3):526-30. PubMed ID: 18342202
    [Abstract] [Full Text] [Related]

  • 9. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M, Pekkinen M, Huttunen M, Lamberg-Allardt C.
    Cell Mol Biol Lett; 2005 Mar 17; 10(2):305-19. PubMed ID: 16010295
    [Abstract] [Full Text] [Related]

  • 10. Pharmacology of a novel, orally active PDE4 inhibitor.
    Dastidar SG, Ray A, Shirumalla R, Rajagopal D, Chaudhary S, Nanda K, Sharma P, Seth MK, Balachandran S, Gupta N, Palle V.
    Pharmacology; 2009 Mar 17; 83(5):275-86. PubMed ID: 19321962
    [Abstract] [Full Text] [Related]

  • 11. Cloning, stable expression of human phosphodiesterase 7A and development of an assay for screening of PDE7 selective inhibitors.
    Malik R, Bora RS, Gupta D, Sharma P, Arya R, Chaudhary S, Saini KS.
    Appl Microbiol Biotechnol; 2008 Jan 17; 77(5):1167-73. PubMed ID: 17952431
    [Abstract] [Full Text] [Related]

  • 12. Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition.
    Oger S, Behr-Roussel D, Gorny D, Denys P, Lebret T, Alexandre L, Giuliano F.
    Eur Urol; 2007 Mar 17; 51(3):772-80; discussion 780-1. PubMed ID: 17097801
    [Abstract] [Full Text] [Related]

  • 13. Cyclic nucleotide-dependent phosphodiesterases (PDEI) inhibition by muscarinic antagonists in bovine tracheal smooth muscle.
    Guerra de González L, González de Alfonzo R, Lippo de Bécemberg I, Alfonzo MJ.
    Biochem Pharmacol; 2004 Aug 15; 68(4):651-8. PubMed ID: 15276072
    [Abstract] [Full Text] [Related]

  • 14. Phosphodiesterase 4 conformers: preparation of recombinant enzymes and assay for inhibitors.
    Bardelle C, Smales C, Ito M, Nomoto K, Wong EY, Kato H, Saeki T, Staddon JM.
    Anal Biochem; 1999 Nov 15; 275(2):148-55. PubMed ID: 10552898
    [Abstract] [Full Text] [Related]

  • 15. Phosphodiesterase 4 inhibitors modulate beta2-adrenoceptor agonist-induced human airway hyperresponsiveness.
    Faisy C, Risse PA, Naline E, Guerot E, Fagon JY, Devillier P, Advenier C.
    Life Sci; 2006 Oct 12; 79(20):1929-35. PubMed ID: 16820175
    [Abstract] [Full Text] [Related]

  • 16. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
    Rutten K, Prickaerts J, Hendrix M, van der Staay FJ, Sik A, Blokland A.
    Eur J Pharmacol; 2007 Mar 08; 558(1-3):107-12. PubMed ID: 17207788
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
    Cheng J, Grande JP.
    Exp Biol Med (Maywood); 2007 Jan 08; 232(1):38-51. PubMed ID: 17202584
    [Abstract] [Full Text] [Related]

  • 19. Functional responses of isolated human seminal vesicle tissue to selective phosphodiesterase inhibitors.
    Uckert S, Bazrafshan S, Scheller F, Mayer ME, Jonas U, Stief CG.
    Urology; 2007 Jul 08; 70(1):185-9. PubMed ID: 17656245
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of new 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine analogs as potential phosphodiesterase-4 inhibitors in NIH-3T3 mouse fibroblastic cells.
    Baeeri M, Foroumadi A, Motamedi M, Yahya-Meymandi A, Firoozpour L, Ostad SN, Shafiee A, Souzangarzadeh S, Abdollahi M.
    Chem Biol Drug Des; 2011 Sep 08; 78(3):438-44. PubMed ID: 21722319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.